DIA revenue rises 16% in H1 2026; guidance unchanged
DIA reported H1 2026 revenue up 16% year-on-year, with EBITDA up 1% and net profit at nearly 147 million PLN. Operating expenses increased faster than revenue, but 2026 guidance was kept unchanged and margins were described as stable.
Story updates
11:49:45 AM UTC
SquawkNews
Revenue grew 16% year-on-year in H1 2026, with strong B2B and preventive program contributions. EBITDA margin remained robust, and guidance for 2026 is unchanged despite higher costs from salary hikes and SAP implementation. Eight acquisitions and a new clinical trials segment signal ongoing expans…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.